Cargando…
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610198/ https://www.ncbi.nlm.nih.gov/pubmed/33162757 http://dx.doi.org/10.2147/CPAA.S282866 |
| _version_ | 1783605153294712832 |
|---|---|
| author | Hendrikx, Jeroen J M A Beijnen, Jos H Huitema, Alwin D R |
| author_facet | Hendrikx, Jeroen J M A Beijnen, Jos H Huitema, Alwin D R |
| author_sort | Hendrikx, Jeroen J M A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7610198 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76101982020-11-05 Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] Hendrikx, Jeroen J M A Beijnen, Jos H Huitema, Alwin D R Clin Pharmacol Letter Dove 2020-10-30 /pmc/articles/PMC7610198/ /pubmed/33162757 http://dx.doi.org/10.2147/CPAA.S282866 Text en © 2020 Hendrikx et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Hendrikx, Jeroen J M A Beijnen, Jos H Huitema, Alwin D R Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title_full | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title_fullStr | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title_full_unstemmed | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title_short | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] |
| title_sort | is bodyweight-based dosing truly better than flat dosing for panitumumab? [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610198/ https://www.ncbi.nlm.nih.gov/pubmed/33162757 http://dx.doi.org/10.2147/CPAA.S282866 |
| work_keys_str_mv | AT hendrikxjeroenjma isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabletter AT beijnenjosh isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabletter AT huitemaalwindr isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabletter |